To evaluate commercially available diagnostic kits for human immunoglobulin G to Toxoplasma gondii, we purchased three enzyme immunoassay (EIA) (Cordia-T, Toxo Bio-EnzaBead, and Toxoelisa), two indirect hemagglutination (IHA) (TPM-Test and ToxllAtest), one fluoroimmunoassay (Toxoplasma-G FIAX), and one latex agglutination (Eiken Toxotest-MT) kit from U.S. suppliers. A total of 100 serum specimens, including 27 that were negative (<1:16) and 73 that were positive for the various titers in the Toxoplasma indirect immunofluorescence (IIF) test, were tested once with each kit; serum samples with discrepant results were retested. Qualitatively, results obtained with the Toxo Bio-EnzaBead EIA, the TMP-Test IHA, and FIAX, and the Toxotest-MT latex agglutination kits agreed exactly with those of 11F. Although all 1F-positive serum samples were detected by the Cordia-T and the Toxoelisa ElAs, four samples determined to be negative by 11F
Bio-EnzaBead (0.7553), and the TPM-Test (0.7206) kits.
The Centers for Disease Control (CDC) receives many requests for information about the usefulness of commercially available kits for the detection of antibodies to Toxoplasma gondii. Although the Food and Drue Administration has established packaging and labeling specifications to which such commercial products must conform when initially approved for marketing in the United States (4) , no postmarketing requirements exist to ensure the continued quality of the kits. Many evaluations of one to three kits have been reported (1-3, 6-9, 12, 13), but results obtained in different laboratories are difficult to compare. We report here the results of a comparison of the sensitivity, specificity, and reactivity of seven nonimmunofluorescence commercial kits available in the United States for the serologic diagnosis of toxoplasmosis by the indirect immunofluorescence (IIF) test.
MATERIALS AND Geometric mean titers were calculated for all specimens at each IIF titer (Fig. 1) . The best agreement was usually found in the IIF titer range of 128 to 1,024. Mean titers determined with the Toxoplasma-G FIAX, Toxo Bio-EnzaBead, and TPM-Test kits were higher than those determined by IIF at a titer of 64, and lower titers were determined by all tests than those determined by IIF at an IIF titer of-4,096.
Cordia-T kit results are reported in international units, as defined by the World Health Organization. When IIF antibody titers were converted to international units and the results compared, serum samples with less than 250 IU consistently had higher titers by the Cordia-T test than by the IIF test, while those with more than 250 IU had lower titers (Fig. 2) .
In the Toxoelisa kit absorbance ranges were used for the classification of results. The six specimens that were negative by IIF but positive by Toxoelisa reacted at values in the low and middle ranges ( .0.65 (high positive) 13 6 50 specifically include the serum samples that were necessary to demonstrate these problems, nor was the reproducibility of the various kits attempted in this study. Several features of the kits may make them more or less attractive to routine diagnostic laboratories ( Table 3 ). The three EIA kits required special equipment and were technically the most difficult, but they had the advantage of providing results within 2 to 2.5 h after the first incubation was begun. The Toxoplasma-G FIAX test also required special equipment, but results were available within 1.5 h. The Cordia-T, Toxoelisa, and Toxoplasma-G FIAX kits required mathematical manipulation of the raw data. AI 
